July 23, 2019
OnKure Executes License and Option Agreement with KDAc Therapeutics
June 11, 2019
OnKure and CU Cancer Center announce first patient enrolled in clinical trial of OKI-179
May 06, 2019
OnKure Announces FDA IND Regulatory Clearance to Start Phase 1 Trials for OKI-179
May 02, 2018
OnKure Close $7M Series A Financing to Support Development of Epigenetics Drug
